Fig. 1: Identification of study population.
HER2 human epidermal growth factor receptor-2, NAHT neoadjuvant anti-HER2 therapy, pCR pathological complete response.
Fig. 1: Identification of study population. | British Journal of Cancer
HER2 human epidermal growth factor receptor-2, NAHT neoadjuvant anti-HER2 therapy, pCR pathological complete response.
